Latest Breaking News On - Hitachi chemical diagnostics inc - Page 2 : comparemela.com

ResearchAndMarkets.com’s offering. Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection. The cargo contained within exosomes can offer prognostic information for a range of diseases – including cardiovascular, renal, neurodegenerative, and metabolic diseases – as well as cancer. Researchers investigating exosome biomarkers have discovered, identified, and reported the presence of hundreds of biomolecules within the lumen of exosomes. This discovery has compelled a rapid rise in exosome-related cancer biomarker research, including the use of exosome

Aruna bioCodiak biosciencesBiocat gmbAnjarium biosciencesTavec pharmaLaura woodAlexerion biotech corpBiovision incAdipomics incOrigene technologies incGuardant health incBeckman coulter life sciencesTheoria science incAvalon globocare corpKimera labs incIzon science ltd